Edition:
United Kingdom

Novavax Inc (NVAX.OQ)

NVAX.OQ on NASDAQ Stock Exchange Global Select Market

6.24USD
23 Aug 2019
Change (% chg)

$-0.40 (-5.96%)
Prev Close
$6.63
Open
$6.53
Day's High
$6.53
Day's Low
$6.06
Volume
98,273
Avg. Vol
201,595
52-wk High
$51.60
52-wk Low
$4.01

Select another date:

Thu, Feb 28 2019

Novavax shares plunge 65 percent as respiratory vaccine fails in late-stage trial

Novavax Inc shares crashed 65 percent on Thursday after data showed its vaccine failed to prevent RSV disease, a leading cause of respiratory infections in infants, missing the main goal of a late-stage study.

UPDATE 1-Novavax respiratory infection vaccine fails in late-stage trial

Feb 28 Novavax Inc said on Thursday its vaccine to prevent RSV infection, a leading cause of a respiratory disease in infants, failed to meet the main goal of a late stage study.

Novavax's respiratory infection vaccine fails in late-stage trial

Feb 28 Novavax Inc said on Thursday its vaccine to prevent RSV infection, a leading cause of a respiratory disease in infants, failed to meet the main goal of a late stage study.

Select another date: